QSCAN GROUP acquired by INFRATIL
Context
Infratil, in partnership with MGIF, acquired a majority stake in Qscan Group from Quadrant Private Equity (QPE) and existing doctor shareholders. The transaction valued the entire group at an enterprise value of AUD 735 million. The deal was structured to provide Infratil with a platform in the high-growth diagnostic imaging market, characterized by aging demographics and the increasing clinical importance of early cancer detection. The acquisition was funded through Infratil's existing debt facilities and cash proceeds from previous divestments, reflecting a shift in their portfolio towards healthcare infrastructure.
QSCAN GROUP, which reported an EBITDA margin of [members only] in 2020, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Qscan is a leading Australian diagnostic imaging provider, specializing in high-complexity services such as PET-CT and oncology imaging. At the time of the deal, it operated over 70 clinics across Australia, including 10 oncology clinics, and was a primary provider for hospital-based radiology services.
Ent. Value
€500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Health Providers
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2020 | ARDIAN | INOVIE GROUP | FRANCE | Labs (Biology) |
| 11/2020 | APHEON (EX ERGON) | VIDACURA | GERMANY | Nursing Homes |
| 10/2020 | KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERS | ELSAN | FRANCE | Clinics / Hospitals |
| 10/2020 | THE VISTRIA GROUP / CENTERBRIDGE PARTNERS | HELP AT HOME | UNITED STATES | Nursing Homes |
| 09/2020 | EQT PARTNERS | COLISÉE | FRANCE | Nursing Homes |
| 09/2020 | VAM INVESTMENTS | DEMENEGO | ITALY | Ophthalmology |
| 07/2020 | BIOGROUP | LABORIZON | FRANCE | Labs (Biology) |
| 07/2020 | ORPEA | BRINDLEY HEALTHCARE | IRELAND | Nursing Homes |
| 06/2020 | ASKLEPIOS KLINIKEN | RHÖN-KLINIKUM | GERMANY | Clinics / Hospitals |
| 03/2020 | ORPEA | TLC GROUP | IRELAND | Nursing Homes |
Other operations with INFRATIL
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 05/2021 | INFRATIL | PACIFIC RADIOLOGY GROUP | NEW ZEALAND | Radiology |
REFERENCES
Valuation range: EV €500M–1.5bn
Revenue range: €100–200M
EBITDA range: €50–100M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of QSCAN GROUP by INFRATIL are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: qscan group
Acquirer: infratil